Cargando…
Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination
Autores principales: | Hsu, Lea, Wisplinghoff, Hilmar, Kossow, Annelene, Hurraß, Julia, Wiesmüller, Gerhard A., Grüne, Barbara, Hoffmann, Dennis, Lüsebrink, Jessica, Demuth, Sabrina, Schildgen, Oliver, Schildgen, Verena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240461/ https://www.ncbi.nlm.nih.gov/pubmed/34214517 http://dx.doi.org/10.1016/j.jinf.2021.06.023 |
Ejemplares similares
-
SARS-CoV-2, CT-Values, and Infectivity—Conclusions to Be Drawn from Side Observations
por: Platten, Martin, et al.
Publicado: (2021) -
COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne)
por: Hsu, Lea, et al.
Publicado: (2021) -
Limits and Opportunities of SARS-CoV-2 Antigen Rapid Tests: An Experienced-Based Perspective
por: Schildgen, Verena, et al.
Publicado: (2021) -
False positive rapid antigen tests for SARS-CoV-2 in the real-world and their economic burden
por: Kretschmer, Andreas, et al.
Publicado: (2022) -
Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
por: Hsu, L., et al.
Publicado: (2022)